SNHG12 and neoplasm: Recently, increasing evidence showed that SNHG12 was also upregulated and contributed to tumor proliferation, invasion, and migration in various tumor tissues, including cervical [11, 12], gastric [13–16], ovarian [17], renal [18], laryngeal [19], lung [20], hepatocellular [21, 22], colorectal [23, 24], prostate [25], nasopharyngeal [26], and breast cancer [27], as well as glioma [28, 29], osteosarcoma [30, 31], and diffuse large B cell lymphoma (DLBCL) [32].